Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

BACKGROUND. Type 2 diabetes mellitus (T2DM) is associated with increased risk of colon cancer (CC), whereas metformin use seems to be protective. However, the impact of metformin use on the risk of death or disease recurrence after radical surgery for CC remains uncertain. MATERIALS AND METHODS. Thi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Vernieri, Claudio, Galli, Fabio, Ferrari, Laura, Marchetti, Paolo, Lonardi, Sara, Maiello, Evaristo, Iaffaioli, Rosario V., Zampino, Maria G., Zaniboni, Alberto, De Placido, Sabino, Banzi, Maria, Damiani, Azzurra, Ferrari, Daris, Rosati, Gerardo, Labianca, Roberto F., Bidoli, Paolo, Frassineti, Giovanni L., Nicolini, Mario, Pavesi, Lorenzo, Tronconi, Maria C., Buonadonna, Angela, Ferrario, Sabrina, Re, Giovanni Lo, Adamo, Vincenzo, Tamburini, Emiliano, Clerico, Mario, Giordani, Paolo, Leonardi, Francesco, Barni, Sandro, Ciarlo, Andrea, Cavanna, Luigi, Gori, Stefania, Cinieri, Saverio, Faedi, Marina, Aglietta, Massimo, Antista, Maria, Dotti, Katia F., Galli, Francesca, Di Bartolomeo, Maria
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519752/
https://ncbi.nlm.nih.gov/pubmed/30606884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0442
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados